文献速递生殖医学

复发性流产风险的潜在NAD相关生物标志物鉴定

Identification of potential NAD-related biomarkers of recurrent miscarriage risk.
PubMed 文献 · Hum Reprod · 2025-01-01

这项前瞻性先导队列研究纳入88名20至40岁非妊娠女性(37例有复发性流产史,51例无),发现复发性流产女性全血、血浆和尿液中NAD补救途径排泄产物1MNA、2PY、4PY浓度升高,尿NAM也升高;血浆1MNA经年龄校正后与复发性流产相关(aOR 1.02;95%CI 1.01,1.03);三代谢物联合年龄的机器学习模型预测准确性最高(AUROC 0.89;95%CI 0.83,0.95)。

要点

  • 复发性流产女性血、血浆和尿中NAD补救途径排泄产物1MNA、2PY、4PY浓度较对照组升高。
  • 血浆1MNA每增加一个单位,复发性流产的比值增加2%(aOR 1.02;95%CI 1.01,1.03)。
  • 1MNA、2PY、4PY联合年龄的机器学习模型预测准确性最高(AUROC 0.89;95%CI 0.83,0.95)。

核心结论

  • 复发性流产女性NAD补救途径排泄产物升高,提示NAD合成途径差异与不良妊娠结局相关。
  • 2PY和4PY在循环和尿液中水平显著不同,可能是与复发性流产相关的潜在生物标志物。
  • 这些代谢物可能不仅是生物标志物,还可能是许多复发性流产病例潜在机制的指标。

研究设计与样本

  • 前瞻性先导队列研究,纳入88名20至40岁非妊娠女性,37例有复发性流产史,51例无。
  • 复发性流产定义为连续两次或以上妊娠<20周的自然流产,且末次流产在招募前6周至2年之间。
  • 研究于2022年3月至2023年12月在澳大利亚悉尼皇家妇女医院(Royal Hospital for Women)进行。
  • 使用经过验证的超高效液相色谱-串联质谱法测量全血、血浆和尿液中NAD及25种相关代谢物水平。

主要发现

  • 全血、血浆和尿液中NAD补救途径排泄产物1MNA、2PY和4PY升高与复发性流产风险较高相关。
  • 这三种代谢物在三种生物基质中呈强正相关,证实三种基质均适合定量这些标志物。
  • 复发性流产女性全血邻氨基苯甲酸和尿NAM水平也升高。
  • 血浆1MNA在单变量分析中与复发性流产相关,校正母亲年龄后效应持续(aOR 1.02;95%CI 1.01,1.03),每增加一个单位,流产比值增加2%。
  • 1MNA、2PY、4PY联合年龄的机器学习模型预测准确性最高(AUROC 0.89;95%CI 0.83,0.95)。

关键数值与推荐

  • 复发性流产定义为连续两次或以上妊娠<20周的自然流产,且末次流产在招募前6周至2年之间。
  • 血浆1MNA与复发性流产的校正比值比(aOR)为1.02(95%CI 1.01,1.03),每增加一个单位,流产比值增加2%。
  • 三代谢物联合年龄模型的AUROC为0.89(95%CI 0.83,0.95)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究在单一医院进行,保证了高内部真实性但可能限制外部真实性。
  • 样本量小,结果需在更大规模研究中重复验证。
  • 测量的NAD相关代谢物水平仅代表采样时的快照,可能不能反映女性怀孕时的情况。
  • 需要在其他人群中进一步评估复发性流产女性的NAD代谢,并评估包括饮食在内的其他关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do women with a history of recurrent miscarriage have altered nicotinamide adenine dinucleotide (NAD)-related metabolites that can be detected in blood, plasma, or urine samples? SUMMARY ANSWER: Women with a history of recurrent miscarriage have higher blood, plasma, and urine concentrations of NAD Salvage Pathway excretion products, and urinary excretion of nicotinamide (NAM) is also elevated, compared to control women. WHAT IS KNOWN ALREADY: Recurrent miscarriage risk is associated with advancing age, high and low BMI, dietary factors, various medical conditions including inflammation, as well as environmental exposures, e.g. to chemicals and pollution. Perturbation of NAD synthesis due to genetic and/or environmental factors causes NAD deficiency, which is implicated in Congenital NAD Deficiency Disorder (CNDD) characterized by recurrent pregnancy loss and congenital anomalies. In CNDD mouse models, foetal anomalies and embryo loss are prevented if NAD levels are raised by supplementing the mother's diet with an NAD precursor, such as vitamin B3, during pregnancy. STUDY DESIGN, SIZE, DURATION: This prospective pilot cohort study included 88 non-pregnant women between 20 and 40 years of age, 37 with and 51 without a history of recurrent miscarriage. Recurrent miscarriage was defined as a history of two or more consecutive spontaneous miscarriages <20 weeks' gestation, with the last miscarriage between 6 weeks and 2 years prior to recruitment. The study was conducted at the Royal Hospital for Women, Sydney, Australia, between March 2022 and December 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants completed a questionnaire about their socio-demographic characteristics, health, lifestyle, diet, medication, and vitamin use; and provided morning fasting blood and urine samples. Levels of NAD and 25 related metabolites were measured in whole blood, plasma, and urine using a validated ultra-high performance liquid chromatography-tandem mass spectrometry method. Differences in NAD metabolism between the groups were assessed by volcano plots and partial least-squares discriminant analysis. Characteristics of women between the two groups were compared using chi-squared statistics. Multivariable generalized additive models were used to assess the association between NAD metabolites and miscarriage. Predictive accuracy of metabolites alone and with age was examined using three machine learning models, including Logistic Regression, Random Forest, and Gradient Boosting Classifier and assessed using the area under the receiver operating characteristic curve (AUROC). MAIN RESULTS AND THE ROLE OF CHANCE: Elevated levels of the metabolites 1-methylnicotinamide (1MNA), N-methyl-2-pyridone-5-carboxamide (2PY), and N-methyl-4-pyridone-3-carboxamide (4PY), representing excretion metabolites of the NAD Salvage Pathway, were associated with a higher risk of recurrent miscarriage. These metabolites showed a strong positive correlation among the three tested biological matrices, confirming the suitability of all three matrices to quantify these markers. Whole blood anthranilic acid and urine NAM levels were also elevated in women with recurrent miscarriage. 1MNA in plasma was associated with recurrent miscarriage on univariate analysis, with the effect sustained after taking into account maternal age (adjusted odds ratio 1.02; 95% CI 1.01, 1.03) with every one-unit increase in 1MNA, the odds of miscarriage increasing by 2%. The predictive accuracy using machine learning approaches was highest when all three metabolites 1MNA, 2PY, and 4PY, and age were included in the model (AUROC 0.89; 95% CI 0.83, 0.95). LIMITATIONS, REASONS FOR CAUTION: This study was conducted in a single hospital, which assures high internal validity but may limit external validity. Sample size was small, and findings should be replicated in larger studies. The measured levels of NAD-related metabolites represent a snapshot at the time of sample collection but might not be reflective of when the women had been pregnant. WIDER IMPLICATIONS OF THE FINDINGS: Our novel finding of elevated excretion of NAM and its derived products in women experiencing recurrent miscarriage suggests differences in the NAD synthesis pathway are linked to adverse pregnancy outcomes. The significant differences in 2PY and 4PY levels in the circulation and urine between the study groups indicate that these metabolites are potential biomarkers associated with recurrent miscarriage. Several conditions which are associated with adverse pregnancy outcomes also affect NAD metabolism and cause elevated levels of these metabolites. Thus, these metabolites may not simply be biomarkers but also be an indicator of the underlying mechanisms in many cases of recurrent miscarriage. Further evaluation of NAD metabolism in women with recurrent miscarriage in other populations and of other associations including diet is required. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by funds to S.L.D. from: the National Health and Medical Research Council (NHMRC), Principal Research Fellowship (ID1135886), Leadership Level 3 Fellowship (ID2007896), and Project Grant (ID1162878); a New South Wales (NSW) Health Cardiovascular Research Capacity Program Senior Researcher Grant; philanthropic support from The Key Foundation, The Ross Trust, and Steven and Linda Harker. N.N. was supported by NHMRC Leadership Level 1 Fellowship (ID1197940) and Financial Markets Foundation for Children. We gratefully acknowledge the Victor Chang Cardiac Research Institute Innovation Centre, funded by the NSW Government, as well as funding from the Freedman Foundation for the Metabolomics Facility. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cuny H, Shand AW, Goth J, et al. Identification of potential NAD-related biomarkers of recurrent miscarriage risk. Hum Reprod. 2025. PMID: 41170824. doi:10.1093/humrep/deaf195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。